Multifocal motor neuropathy (MMN) is a demyelinating neuropathy characterized by predominant involvement of motor nerves. MMN can mimic ALS and other lower motor neuron diseases, but, as MMN is treatable by intravenous immune globulin (IVIg) and other immunomodulating therapies (1), its differential diagnosis is important. The diagnosis of MMN is particularly difficult when its diagnostic hallmarks, conduction block (CB) and anti-ganglioside antibody are not demonstrable. In a recent study, CB was identified in only 60% of MMN patients (2). Sonography of the peripheral nerves was recently reported to detect signs of widespread demyelination including in proximal nerve segments of MMN patients with CB (3). Thus, the aim of the present study was to assess whether sonography of the nerve roots can identify nerve hypertrophy as a suggestive evidence of demyelination in MMN patients without CB and further, to help differentiate MMN from ALS. ALS was chosen for comparison because MMN is still one of the most common masqueraders of ALS when upper motor neuron sign is not obvious.
INTRODUCTION
Multifocal motor neuropathy (MMN) is a demyelinating neuropathy characterized by predominant involvement of motor nerves. MMN can mimic ALS and other lower motor neuron diseases, but, as MMN is treatable by intravenous immune globulin (IVIg) and other immunomodulating therapies (1) , its differential diagnosis is important. The diagnosis of MMN is particularly difficult when its diagnostic hallmarks, conduction block (CB) and anti-ganglioside antibody are not demonstrable. In a recent study, CB was identified in only 60% of MMN patients (2) . Sonography of the peripheral nerves was recently reported to detect signs of widespread demyelination including in proximal nerve segments of MMN patients with CB (3). Thus, the aim of the present study was to assess whether sonography of the nerve roots can identify nerve hypertrophy as a suggestive evidence of demyelination in MMN patients without CB and further, to help differentiate MMN from ALS. ALS was chosen for comparison because MMN is still one of the most common masqueraders of ALS when upper motor neuron sign is not obvious.
SUBJECTS AND METHODS

Subjects
Recordings were made from nine patients with MMN (all men), 22 with ALS (15 men), and from 17 normal controls (11 men) in Tokushima University Hospital, Japan. All the patients with MMN and ALS were ambulatory. The inclusion criteria for the patients with MMN were the following : (A) progressive muscle atrophy and weakness involving only a few peripheral nerves or roots, without sensory involvement, (B) lack of upper motor neuron signs, pathological reflexes, or bulbar symptoms/signs, (C) the lack of radiological abnormality of the cervical spine in an MRI scan, (D) lack of CB according to published electrodiagnostic criteria (4), and (E) most importantly, the presence of clinical improvement of the affected limb with IVIg therapy (2 g/kg given over 5 consecutive days), defined as the improvement of the pre -versus post-therapeutic modified MRC score (1 -5 scale including 4 -and 4 + grades) equal to or greater than 2 in at least two of the affected muscles (5, 6) . The mean duration of our clinical follow up of the MMN patients was 42.3 months (range : 18 -107 months) and all the patients remained ambulatory. The mean number of patients undergoing IVIg treatment was 9.9 (range : 4 -17) with reproducible post-therapeutic improvement.
Inclusion criterion for the ALS group was to meet either the clinically definite, or clinically probable (with or without laboratory support) revised El Escorial ALS criteria. Of note, our ALS patients had predominantly lower motor involvement at the time of the sonographic assessment, thus its clinical distinction from MMN was not straightforward. The control group was made up of individuals with no neurological symptoms or signs. Either MRI or plain four-angle x-ray of the cervical spine was performed in the control subjects to confirm the lack of significant degenerative spine disease. All the patients and control subjects gave informed consent to participate in the study. This study was performed in accordance with the principles embodied in the Declaration of Helsinki and was approved by the Institutional Review Board at Tokushima University.
Nerve conduction study
Nerve conduction studies were performed with percutaneous stimulating and recording electrodes (Viking IV, Nicolet, Madison, USA). Compound muscle action potentials (CMAP) were elicited with distal and proximal stimulation of the median nerve (at the wrist with 7 cm stimulating-recording distance and at the elbow) and of the ulnar nerve (at the wrist with 7 cm stimulating -recording distance and on the forearm below the elbow). Distal motor latencies (DL) and motor nerve conduction velocities (CV) were then computed. Sixteen to 32 stimulations at 1 Hz were given to elicit at least 10 F-waves and their minimum latency was recorded. Additional sites of stimulation (axilla and Erb's point for the median nerve and above the elbow ; axilla and Erb's point for the ulnar nerve) demonstrated neither CB nor temporal dispersion in any of the subjects. Tibial and peroneal nerves were also stimulated according to standard techniques, and DLs and CVs were within normal limits in all subjects.
Sonography
The cervical roots were visualized by high-resolution echosonography (Nemio, Toshiba, Japan) using an 11 -MHz linear probe. The subjects were examined in the supine position with the head turned upward. By placing the probe on the lateral aspect of the neck, a coronal oblique plane enabled a longitudinal view of the cervical roots, which were seen as hypoechoic structures, and easy measuring of their diameters at a point 2 cm distal to the transverse process. The C6 nerve root was easily identified, as the neighboring C6 vertebra is characterized by a vertebral artery passing through its transverse foramina and by its prominent anterior tubercle compared with that of the C7 vertebra. The C5 and C6 nerve roots were identified and their diameters measured. As the C7 and C8 roots may not be visualized in some patients, especially in obese individuals, we analyzed only C5 and C6 roots. The nerve roots appeared to be round, thus the measurements were not influenced by flattening. As the lower cervical roots were deep and their measurements possibly inaccurate, they were excluded from the present study. The sonography technician was blind to the clinical diagnoses.
Statistical analysis
ANOVA withBonferroni post hoc analysis (for comparison among MMN, ALS, and control groups) was used for data analysis (SPSS 20.0, Chicago, U.S.A.). P-values less than 0.05 were considered to be significant.
RESULTS
The clinical and electrodiagnostic data are summarized in Table 1 . The average age of the MMN patients was slightly less than that of the other two groups due to one young patient. Other than the male dominancy in MMN, the clinical features were similar among the groups. In MMN, two patients had shoulder involvement, five had predominantly forearm and finger involvement, and one had diffuse arm weakness. There were no significant electrodiagnostic differences between the MMN and ALS patients. Among the control subjects, eight had cervical MRI and nine had plain cervical x -ray, none of whom showed evidence of significant degenerative spine disease. Figure 1A shows the sonographic finding of an MMN patient with a thick C6 nerve root suggestive of demyelination. In Figure 1B , the MRI imaging corroborated the sonographic finding. As a group, the patients with MMN had larger nerve root diameters than those with ALS or the control groups, with the normal upper limit of both the C5 and C6 diameters being 4.0 mm (Figures 2 and 3 ). Of note, the root diameters in MMN were asymmetric, with the clinically affected roots tending to show increased diameters. In MNN patients, the percentage of thick C6 nerve roots was higher than that of C5 roots (77% vs. 55%, respectively) on the clinically dominant side, likely reflecting the clinical involvement in our MMN patients. By contrast, the root diameters of some ALS patients were thinner than those of controls, suggesting axonal degeneration.
DISCUSSION
In the present study, we have shown that sonography can detect focal thickness of a cervical nerve root in MMN to suggest demyelination that can differentiate MMN from ALS, which has been demonstrated to have pathologically thinner nerve roots due to atrophy (7), and from normal controls.
The role of peripheral nerve sonography to detect nerve enlargement and changes in echogenicity have been previously described. Demyelinating neuropathies such as chronic inflammatory demyelinating polyneuropathy (CIDP) and Charcot-Marie -Tooth disease show diffusely thickened peripheral nerves and nerve roots (8, 9) . MRI and sonography are also able to detect focal enlargement of nerves, plexuses and nerve roots due to infection, inflammation, infiltration and neoplasm (10) . Recent comparison between MRI and sonography in CIDP showed that the two techniques are relevant in detecting microstructure such as nerve fascicles, such that sonography could replace MRI in daily practice due to its affordability (11) .
In MMN, peripheral nerves at the sites of CB and at electrodiagnostically normal sites were reported to be demyelinated (12, 13) and demonstrated increased diameters by MRI (14) . This finding was confirmed by a recent report employing high resolution sonography in MMN patients (3, 15, 16) , but its utility for differential diagnosis, especially in MMN patients without solid diagnostic evidence (e.g., CB and/or anti-ganglioside antibodies), had been little explored. We have thus demonstrated that, in patients with otherwise typical MMN but no overt CB, sonography can provide evidence of demyelination. Sonography would be particularly useful in diagnosing a patient with predominantly lower motor neuron involvement and in predicting the therapeutic efficacy of intravenous immunoglobuiln in MMN (17) .
That said, some of the MMN patients in the present study had normal root diameters and several explanations are possible : (A) the demyelination was focal and the examined C5 or C6 nerve roots were not significantly affected, (B) the roots were initially thickened, but later became thinner due to secondary axonal degeneration, (C) the focal demyelination existed somewhere other than at the root level, and (D) the presence of chronic motor axonal neuropathy, which shows no clear evidence of demyelination, but has only axonal degeneration (i.e., thinning of the peripheral nerve) (18) .
Because sonographic detection of nerve thickness has also been reported in other demyelinating neuropathies, the finding should (Figure 2 ), the mean diameters were larger in MMN than in both the control and ALS groups. The root diameters of some of the ALS patients were thinner than the controls, suggestive of axonal degeneration.
be interpreted according to the clinical information. A novice echosonographer may not be able to obtain the appropriate crosssectional and longitudinal images, leading to either over -or underdiagnosis of nerve swelling and atrophy. However, under an experienced hand, measurements of a nerve size have been reported to have high intra-and inter -observer reliability. By using similar recording methods, Sugimoto, et al. reported coefficients of variation in normal individuals. Their intra-and inter -observer coefficients of variation of the C5 -C7 nerve roots ranged from 5.5 to 14.3% (19) . Another limitation is that we did not compare the sizes of the nerve roots by sonography and MRI in all the subjects. Although MRI might have lower operator-dependency than sonography, MRI might not depict nerve roots with the largest cross-sectional plane, thus accurate comparison might not be possible.
Despite this limitation and its non-specificity, sonographic detection of nerve thickness may suggest focal demyelination and thus may support the diagnosis of MMN, especially in those cases without overt CB.(2) Further study is needed to elucidate the locations of the "electrically silent" nerve swelling and thus suggest a diagnostic protocol to detect such likely demyelinating lesions.
